Search - tctmd.com

Displaying 721 - 740 of 827

Sort: Relevancy | Date

Presentation TCT 2015

How Would I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

Presenter: Run-Lin Gao, Martin B. Leon, Bo Xu, Mao Chen

October 11, 2015

Presentation TCT 2015

How Should I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

Presenter: Run-Lin Gao, Martin B. Leon, Bo Xu, Yongjian Wu

October 11, 2015

Presentation TCT 2015

KEYNOTE LECTURE: Transcatheter Valve Replacement for Bioprosthetic Valve Failure Gold Standard vs Selective Application (The VIVID Registry)

Presenter: Martin B. Leon, Neil E. Moat, Danny Dvir

October 11, 2015

Presentation

Outcomes Up to 7 Years After Transcatheter Pulmonary Valve Replacement With the Melody Valve

Presenter: John P. Cheatham

May 13, 2015

Presentation

Postoperative Delirium Increases Mortality After Surgical or Transcatheter Aortic Valve Replacement

Presenter: Hersh S. Maniar

May 01, 2015

Presentation ACC 2015

Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial

Presenter: Michael J. Mack

March 15, 2015

Presentation ACC 2015

A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed at Increased Risk for Surgery 2-Year Outcomes

Presenter: Michael J. Reardon

March 15, 2015

Presentation

Clinical Outcomes at 1 Year Following Transcatheter Aortic Valve Replacement

Presenter: David Holmes Jr.

March 10, 2015

Presentation Cardiovascular Interventions 2014

Transcatheter Aortic Valve Replacement: State of the Art

Presenter: Paul S. Teirstein

October 23, 2014

Presentation Cardiovascular Interventions 2014

Transcatheter Aortic Valve Replacement (TAVR)

Presenter: Paul S. Teirstein

October 23, 2014

Presentation TCT 2014

TCT 700: Multicenter Evaluation of Transcatheter Aortic Valve Replacement Using Either SAPIEN XT or CoreValve: Degree of Device Oversizing and Clinical Outcomes

Presenter: Danny Dvir

September 16, 2014

Presentation TCT 2014

TCT 701: A Multidisciplinary, Multimodality but Minimalist (3M) Approach to Transfemoral Transcatheter Aortic Valve Replacement Facilitates Safe Next-Day Discharge Home in High-Risk Patients: 1-Year Follow-up

Presenter: Danny Dvir

September 16, 2014

Presentation TCT 2014

TCT 699: The Effect of Tricuspid Regurgitation and Right Ventricular Dysfunction on Mortality in High-Risk Patients Undergoing Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER II Inoperable Cohort

Presenter: James B. Hermiller Jr, Susheel Kodali, Augusto D. Pichard, Alan Zajarias

September 16, 2014

Presentation TCT 2014

TCT 697: Is Transcatheter Aortic Valve Replacement the Best Option for Patients with Severe Aortic Stenosis and Small Aortic Annulus? Insights from the PARTNER Trial

Presenter: Philippe Pibarot, Allan Schwartz, Gary Gershony, Josep Rodés-Cabau

September 16, 2014

Presentation TCT 2014

TCT 693: Influence of Body Mass Index on Survival of Aortic Stenosis Patients Treated by Transcatheter Aortic Valve Replacement: Insights on the Obesity Paradox from the PARTNER Trial

Presenter: Thomas F. Luscher, Danny Dvir

September 16, 2014

Presentation TCT 2014

Transcatheter pulmonary valve replacement with the Edwards-Sapien Valve: The Toronto Congenital Cardiac Centre for Adults Experience

Presenter: William Wilson

September 16, 2014

Presentation TCT 2014

The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients

Presenter: Christopher Meduri

September 16, 2014

Presentation TCT 2014

Comparison of 30-day Major Vascular Complications between Transfemoral and Transapical Accesses in Transcatheter Aortic Valve Replacement: an Updated Meta-Analysis using___

Presenter: Rhanderson Cardoso

September 16, 2014

Presentation TCT 2014

Clinical Impact and Evolution Of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-Analysis

Presenter: Luis Nombela-Franco

September 16, 2014

Presentation TCT 2014

The Role of Right Sided Hemodynamic Parameters as Predictors of 30 Day Outcome After Transcatheter Aortic Valve Replacement: The Impact of Right Ventricular Stroke Work Index

Presenter: Rajiv Tayal

September 16, 2014

Advertisement

How Would I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

How Should I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

KEYNOTE LECTURE: Transcatheter Valve Replacement for Bioprosthetic Valve Failure Gold Standard vs Selective Application (The VIVID Registry)

Outcomes Up to 7 Years After Transcatheter Pulmonary Valve Replacement With the Melody Valve

Postoperative Delirium Increases Mortality After Surgical or Transcatheter Aortic Valve Replacement

Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial

A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed at Increased Risk for Surgery 2-Year Outcomes

Clinical Outcomes at 1 Year Following Transcatheter Aortic Valve Replacement

Transcatheter Aortic Valve Replacement: State of the Art

Transcatheter Aortic Valve Replacement (TAVR)

TCT 700: Multicenter Evaluation of Transcatheter Aortic Valve Replacement Using Either SAPIEN XT or CoreValve: Degree of Device Oversizing and Clinical Outcomes

TCT 701: A Multidisciplinary, Multimodality but Minimalist (3M) Approach to Transfemoral Transcatheter Aortic Valve Replacement Facilitates Safe Next-Day Discharge Home in High-Risk Patients: 1-Year Follow-up

TCT 699: The Effect of Tricuspid Regurgitation and Right Ventricular Dysfunction on Mortality in High-Risk Patients Undergoing Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER II Inoperable Cohort

TCT 697: Is Transcatheter Aortic Valve Replacement the Best Option for Patients with Severe Aortic Stenosis and Small Aortic Annulus? Insights from the PARTNER Trial

TCT 693: Influence of Body Mass Index on Survival of Aortic Stenosis Patients Treated by Transcatheter Aortic Valve Replacement: Insights on the Obesity Paradox from the PARTNER Trial

Transcatheter pulmonary valve replacement with the Edwards-Sapien Valve: The Toronto Congenital Cardiac Centre for Adults Experience

The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients

Comparison of 30-day Major Vascular Complications between Transfemoral and Transapical Accesses in Transcatheter Aortic Valve Replacement: an Updated Meta-Analysis using___

Clinical Impact and Evolution Of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-Analysis

The Role of Right Sided Hemodynamic Parameters as Predictors of 30 Day Outcome After Transcatheter Aortic Valve Replacement: The Impact of Right Ventricular Stroke Work Index

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content